BioSpace News Archive

Deals

Medical Marijuana, Inc. Subsidiary Kannaway® Receives Two 2019 BIG Awards for Business

Medical Marijuana, Inc. announced that its subsidiary Kannaway® was named Small Business Company of the Year in the Life Sciences, Health, Wellness, and Nutrition category by the Business Intelligence Group’s 2019 BIG Awards for Business.

November 6, 2019
·
5 min read
BioCapital

Thermo Fisher Scientific Introduces First Next-Generation Sequencing Platform That Delivers Specimen to Report in a Single Day

Ion Torrent Genexus System* holds potential to advance precision medicine in the clinic

November 6, 2019
·
6 min read
Pharm Country

Regeneron to Report Results from CD20xCD3 and BCMAxCD3 Bispecifics and C5 Antibody Programs at ASH Annual meeting

New data is from programs in B-cell non-Hodgkin lymphoma, multiple myeloma and paroxysmal nocturnal hemoglobinuria

November 6, 2019
·
11 min read
Sierra Oncology to Report New Analyses Supporting Momelotinib’s Anemia Benefits at ASH 2019

New dynamic analyses of Phase 3 SIMPLIFY-1 transfusion data demonstrate that momelotinib patients are nearly 10-times more likely to remain transfusion free compared to ruxolitinib treated patients

November 6, 2019
·
9 min read
Business

The American Academy of Orthopaedic Surgeons (AAOS) Partners with CareCredit to Help Improve the Financial Experience for Orthopaedic Surgeons and Patients

The American Academy of Orthopaedic Surgeons, the preeminent provider of education and practice management services for orthopaedic surgeons and allied health professionals has entered a new partnership with CareCredit, a leading health, wellness and personal care credit card business.

November 6, 2019
·
4 min read
Business

Axogen, Inc. Reports 2019 Third Quarter Financial Results

Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves, today reported financial results and business highlights for the third quarter ended September 30, 2019.

November 6, 2019
·
15 min read
Bioeq Announces Coherus as Marketing and Distribution Partner for Its Biosimilar to Lucentis® (ranibizumab) in the U.S.

Bioeq IP AG (“Bioeq”) today announced that it signed a license and development agreement with Coherus BioSciences, Inc. (“Coherus” Nasdaq:CHRS), under which Coherus will exclusively market and distribute Bioeq’s biosimilar candidate to Lucentis® (ranibizumab) in the United States (U.S.)

November 6, 2019
·
2 min read
Business

Vanda Pharmaceuticals Reports Third Quarter 2019 Financial Results

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced financial and operational results for the third quarter ended September 30, 2019.

November 6, 2019
·
10 min read
Business

Tocagen to Report Third Quarter 2019 Financial Results and Business Updates on Tuesday, November 12

Tocagen Inc., a clinical-stage, cancer-selective gene therapy company, announced it will report its third quarter 2019 financial results and business progress on Tuesday, November 12, 2019, after the close of the U.S. financial markets.

November 6, 2019
·
1 min read
Business

PDL BioPharma Reports 2019 Third Quarter Financial Results

Revenues of $44.2 million includes continued growth from LENSAR and strong contribution from royalty assets

November 6, 2019
·
17 min read